ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,908, issued on Nov. 25, was assigned to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (Tampa, Fla.).

"Antibodies against programmed cell death protein 1 (PD1) and uses thereof" was invented by Jose Conejo-Garcia (Tampa, Fla.) and Subir Biswas (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are novel PD1 binding molecules and methods of their use."

The patent was filed on March 30, 2020, under Application No. 17/599,875.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f...